Working… Menu

The Effect of Honey on Xerostomia and Oral Mucositis (AC-H)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01465308
Recruitment Status : Completed
First Posted : November 4, 2011
Last Update Posted : October 8, 2014
Information provided by (Responsible Party):
Dr. Andreas Charalambous, Cyprus University of Technology

Brief Summary:
The purpose of this study is to determine whether the use of pure honey will help in the treatment of radiation induced xerostomia and oral mucositis (symptom management)

Condition or disease Intervention/treatment Phase
Head and Neck Cancer Dietary Supplement: Honey mouthwash Other: Normal Saline Phase 2

Detailed Description:
Radiation-induced mucositis is a normal acute side effect of radiotherapy treatment. Exposure of ionising radiation to oral, pharyngeal and laryngeal mucosa gives rise to radiation epithelitis towards the second and third weeks of conventional fractionated radiotherapy. Likewise, salivary flow may decrease by approximately 50% during the first week of radiotherapy and upwards of 80% by the seventh week of treatment. Acute radiation-induced xerostomia is associated with inflammatory reaction. The study will include an intervention and a control group, one receiving honey prior and after the radiotherapy and the other group not receiving honey at all.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 72 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: A Randomized Control Trial for the Effect of Honey on Radiotherapy Induced Xerostomia and Oral Mucositis in Patients With Head and Neck Cancers
Study Start Date : August 2011
Actual Primary Completion Date : September 2014
Actual Study Completion Date : October 2014

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: receiving Honey
The patients will receive honey mouthwash rinses
Dietary Supplement: Honey mouthwash
The patients in the intervention group will receive honey mouthwash 15 minutes before the radiotherapy session, 15 minutes after and 6 hours after the radiotherapy session

Active Comparator: Saline mouthwash
The patients in this group will receive saline rinses
Other: Normal Saline
Saline rinses 15 minutes before radiotherapy, 15 minutes after, and 6 hours after radiotherapy

Primary Outcome Measures :
  1. Change from baseline in Xerostomia grades [ Time Frame: 1 week, 2 weeks, 3 weeks, 4 weeks ]
  2. Change from baseline in oral mucositis grades [ Time Frame: 1 week, 2 weeks, 3 weeks, 4 weeks ]

Secondary Outcome Measures :
  1. Changes in the General satisfaction of comfort [ Time Frame: 1 week, 2 week, 3 week, 4 week ]
  2. Change in baseline weight in one month [ Time Frame: 4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients who receive radiotherapy (RT) to the oral cavity will be included in the study.
  • Patients with a confirmed histologic diagnosis of head and neck cancer referred to non-palliative radiotherapy will enter into this trial.
  • aged over 18
  • receiving radiotherapy for at least four weeks

Exclusion Criteria:

  • Allergic to honey
  • confirmed and medically treated diabetes mellitus

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01465308

Layout table for location information
Bank of Cyprus Oncology Centre
Nicosia, Cyprus, 2006
Sponsors and Collaborators
Cyprus University of Technology
Layout table for investigator information
Principal Investigator: Andreas Charalambous, PhD Cyprus University of Technology
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Dr. Andreas Charalambous, Lecturer-Researcher, Cyprus University of Technology Identifier: NCT01465308    
Other Study ID Numbers: AC-HANHS-86
First Posted: November 4, 2011    Key Record Dates
Last Update Posted: October 8, 2014
Last Verified: October 2014
Keywords provided by Dr. Andreas Charalambous, Cyprus University of Technology:
head and neck cancer
radiotherapy induced xerostomia
radiotherapy induced oral mucositis
symptom management
Additional relevant MeSH terms:
Layout table for MeSH terms
Head and Neck Neoplasms
Neoplasms by Site
Gastrointestinal Diseases
Digestive System Diseases
Mouth Diseases
Stomatognathic Diseases
Salivary Gland Diseases